Filing Details
- Accession Number:
- 0001447362-21-000130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-10 17:06:42
- Reporting Period:
- 2021-06-08
- Accepted Time:
- 2021-06-10 17:06:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1447362 | Castle Biosciences Inc | CSTL | Services-Medical Laboratories (8071) | 770701774 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1782994 | E. Bernhard Spiess | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Ste. 401 Friendswood TX 77546 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-08 | 8,989 | $1.92 | 22,551 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-06-08 | 8,989 | $70.00 | 13,562 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2021-06-08 | 8,989 | $0.00 | 8,989 | $1.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,878 | 2026-05-23 | No | 4 | M | Direct |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 24, 2021.
- Includes 1,815 shares acquired on February 26, 2021 under the Issuer's employee stock purchase plan.
- 25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.